Yes Akkermansia strengthens the gut barrier, reduces inflammation, improves GLP-1 sensitivity, and supports fat metabolism
In that extension, participants assigned to the 12 mg-to-maximum-tolerated-dose path averaged 30.3% body-weight reduction
Semaglutide and tirzepatide are meant to be used as alternatives, not together
The Evidence: What Research Says In the SUSTAIN-6 clinical trial , Semaglutide demonstrated its ability to reduce the progression of kidney disease in patients with Type 2 diabetes
IgG4-RD can affect a variety of tissues (pancreas, skin, salivary glands, lacrimal glands, etc.), and the hallmarks are lymphoplasmacytic infiltrations with predominance of IgG4-positive plasma cells and fibrosis in the affected tissue
GLP-1 has been shown to attenuate the effect of arginine dysregulation and RAGE activation, which is one of the mechanisms of airway inflammation reduction [85]